Novonesis biosolutions for human health – advancing well-being through science-driven innovation
Eliminate Crosslinking
April 2025

The RXL® portfolio comprises four specially designed gelatin solutions that reduce crosslinking in softgel capsules. They are designed to produce softgels with enhanced stability, longer shelf life, and consistently good fill release – no matter how tricky the fill. This paper will guide you through the RXL® portfolio and its possibilities.

Technical paper is brought to you by Gelita. 

NutritionInsight Global EMEA
trans